Tedizolid phosphate alleviates DSS-induced ulcerative colitis by inhibiting senescence of cell and colon tissue through activating AMPK signaling pathway
Authors:
- Min ZhouMZMin Zhou
- Zhen-Lin LiuZLZhen-Lin Liu
- Jia-Yu LiuJLJia-Yu Liu
- Xiao-Bo WangXWXiao-Bo Wang
- 21 May 2024
- journal article
- research article
- Published by Elsevier in International Immunopharmacology
- Vol. 135
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Hallmarks of aging: An expanding universeCell, 2023
- Anti-inflammation and anti-aging mechanisms of mercaptopurine in vivo and in vitroBiochemical and Biophysical Research Communications, 2022
- Role of AMPK mediated pathways in autophagy and agingBiochimie, 2022
- Polysaccharides from natural resources exhibit great potential in the treatment of ulcerative colitis: A reviewCarbohydrate Polymers, 2021
- Analysis of Aged Dysfunctional Intestinal Stem Cells2020
- CO ameliorates endothelial senescence induced by 5-fluorouracil through SIRT1 activationArchives of Biochemistry and Biophysics, 2019
- Cellular Senescence: Defining a Path ForwardCell, 2019
- Intra- and Inter-cellular Rewiring of the Human Colon during Ulcerative ColitisCell, 2019
- Colorectal cancer prevention in patients with ulcerative colitisBest Practice & Research Clinical Gastroenterology, 2018
- Pharmacokinetics of Tedizolid Following Oral Administration: Single and Multiple Dose, Effect of Food, and Comparison of Two Solid Forms of the ProdrugPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2013